Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.93
-0.04 (-0.57%)
At close: Nov 20, 2024, 4:00 PM
6.72
-0.21 (-3.03%)
Pre-market: Nov 21, 2024, 4:23 AM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $324.31 million as of November 21, 2024. Its market cap has decreased by -9.95% in one year.
Market Cap
324.31M
Enterprise Value
151.61M
1-Year Change
-9.95%
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $324.31M, a decrease of -39.76%. That is a compound annual growth rate of -11.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 324.31M | -51.72% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Semler Scientific | 324.29M |
| COMPASS Pathways | 323.63M |
| Lexicon Pharmaceuticals | 321.55M |
| Delcath Systems | 319.74M |
| Nyxoah | 316.15M |
| Design Therapeutics | 313.80M |
| Sanara MedTech | 313.72M |
| Alpha Teknova | 311.29M |